Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes

I Taddei, M Morishima, T Huynh… - Proceedings of the …, 2001 - National Acad Sciences
I Taddei, M Morishima, T Huynh, EA Lindsay
Proceedings of the National Academy of Sciences, 2001National Acad Sciences
The del22q11 syndrome is associated with a highly variable phenotype despite the
uniformity of the chromosomal deletion that causes the disease in most patients. Df1/+ mice,
which model del22q11, present with reduced penetrance of cardiovascular defects similar to
those seen in deleted patients but not with other del22q11-like findings. The reduced
penetrance of cardiovascular defects is caused by the ability of mutant embryos to recover
from a fourth pharyngeal arch artery growth abnormality that is fully penetrant in early …
The del22q11 syndrome is associated with a highly variable phenotype despite the uniformity of the chromosomal deletion that causes the disease in most patients. Df1/+ mice, which model del22q11, present with reduced penetrance of cardiovascular defects similar to those seen in deleted patients but not with other del22q11-like findings. The reduced penetrance of cardiovascular defects is caused by the ability of mutant embryos to recover from a fourth pharyngeal arch artery growth abnormality that is fully penetrant in early embryos. Here we show that genetic background has a major effect on penetrance of cardiovascular defects by affecting this embryonic recovery process. This effect could not be explained by allelic variation at the haploid locus, and it is likely to be caused by genetic modifiers elsewhere in the genome. We also show that genetic factors control extension of the Df1/+ phenotype to include thymic and parathyroid anomalies, establishing the Df1 mouse as a model for the genetic analysis of three major features of human del22q11 syndrome. We found that in Df1/+ mice, as in human patients, expression of the heart and thymic phenotypes are essentially independent from each other, suggesting that they may be controlled by different genetic modifiers. These data provide a framework for our understanding of phenotypic variability in patients with del22q11 syndrome and the tools for its genetic dissection.
National Acad Sciences